Frontier Ip Share Discussion Threads

[acuere] 24/3/2023 12:40

The new Alusid tile range hinted at in the HY results has now been launched. It comes from Parkside the commercial arm of Topps Tiles.



And a bit of industry comment on the launch.

[acuere] 22/3/2023 10:10

Exscientia results out 12.30 tomorrow.

Meanwhile an article here gives good info about their partners, progress of projects and potential revenues.

[hastings] 20/3/2023 20:57

https://pulsiv.co.uk/articles/pulsiv-osmium-eliminates-inrush-current/

[hastings] 18/3/2023 16:30

The next funding round for Pulsiv will, I believe, give us a real taste of the potential ahead. As the CEO said, they've been planning well ahead, so very much exciting times.

[aqc888] 18/3/2023 14:55

It would seem companies signing agreements with Pulsiv seem to understand the huge potential and market. I’d also presume many of these think it’s not possible to buy shares in Pulsiv. Perhaps a small bit of marketing from frontier ip to this group would generate a fair bit of buying. I’d even suggest a company like Salom might consider buying Frontier ip just to get its hands on the valuable 20% Pulsiv stake. After you strip out cash and liquid exscientia shares it would be a fair value just for Pulsiv. Exciting times.

[best1467] 17/3/2023 18:45

Apologies it’s correct I must have been getting mixed up with one of the other holdings

[best1467] 17/3/2023 18:39

They invested in the latest Pulsiv to maintain their 20% ish stake I thought so not sure if that note from VSA is correct stating 18%

[acuere] 17/3/2023 14:28

Pulse has signed a strategic agreement with a leading US manufacturer’s rep covering 7 key southern states.



Hopefully we’ll start getting News on design wins soon.

[bomber13] 16/3/2023 19:51

Exscientia is up nearly 5% tonight at just under $7 , and their management has already presented at 3 healthcare conferences this March so far . Their Q4 and full year figures are next Thursday , 23rd March followed by a conference call and webcast . The company has also had data from 4 abstracts accepted for poster presentation at the big AACR conference in Orlando between 14th - 19th April 2023 .

Here is what Exscientia recently said about the data -

" These new data demonstrate the potential of integrating outstanding science with cutting-edge AI, to efficiently identify novel targets with the potential for increased probability of clinical success. We also believe that our platform can be used to predict outcomes that help identify cancer patients with high unmet need who may benefit most from treatment. We look forward to advancing these programmes and expanding our pipeline with the goal of developing precision-designed, truly personalised medicines for patients around the world.”


At around $7 , Frontier's residual holding of 782400 shares in Exscientia is worth £4.5m , some 10% of its NAV or 13% of its market cap . Frontier last sold stock well above current levels at $12 last year , and here is what the company said about its remaining investment in the recent interim report - " Exscientia is already established as a world leader in using artificial intelligence in drug discovery and we are confident about its future potential " .

Sounds like we shouldn't expect any further sales until the Exscientia shareprice is a lot higher ?

[cordwainer] 16/3/2023 14:55

Sorry I missed a few letters according to her wiki profile:
DBE FRS FRAeS FInstP CEng FREng
(I can't find other references to FMedSci)

cordwainer15 Mar '23 - 14:38 - 404 of 416 Edit
0 2 0
I would not want to fence words much with Dame Julia King, Baroness Brown of Cambridge DBE FREng FRS FMedSci. Glad she is on our side.

[hastings] 16/3/2023 12:51

It'll be interesting to see who else comes on board when Pulsiv undertakes it's next and most likely most significant raise.

[acuere] 16/3/2023 11:43

According to Pulsiv website these were the 2021 sales figures of most popular target items:
Laptops sales: 276 million units
Television sales: 178 million units
Tablet sales: 168 million units

In addition they report that there were 6.37 billion smartphone users who on average have 3 chargers.

Elsewhere I found
Microwaves: 30 million
Game Consoles: 46 million (that’s Nintendo Switch, PS5, XBox)
and there’s a whole host of others.
I’ll let others take a guess on what sort of potential revenues could be available.

[rivaldo] 16/3/2023 11:33

There's a new note on FIPP on Research Tree from VSA Capital. It concludes "The current discount to NAV represents an ideal opportunity to gain exposure to technology companies that are approaching commercialisation and, if they are successful, this would see distinct appreciation in FIPP’s NAV."

There's a nice summary of progress at Pulsiv and Alucid which are highlighted as being at commercialisation inflection points:

"Pulsiv (stake 18.3%) has developed patented, high energy efficiency, power conversion technology that converts electricity from AC to DC and vice versa. Products have been developed for mains powered products, battery chargers,
lighting applications, DC motors, and solar panels. The valuation of the Group’s investment at 1H23 close was £9.5m. FIPP notes that during 1H23, Pulsiv made solid technical and commercial progress, securing strategic distribution agreements with Astute Electronics, Digikey Electronics, the (world's fifth largest electronic components distributor), ISMOsys and Pankaj Electronics. Pulsiv, also entered a collaboration with U.S. based Salom, a major manufacturer of power supplies whose customers include Dyson, Lenovo, Motorola, Panasonic and Philips. As we have previously noted, the market opportunity for Pulsiv is global and significant. Market research house ReportLinker estimates that the micro inverter electronics market, which Pulsiv addresses, has a market size which is expected to reach US$7.4 billion by 2028, rising at a market growth of 17.8% CAGR from 2022.

Alusid (stake 38.9%) produces premium-quality tiles, tabletops and other surfaces by recycling industrial waste, ceramics and glass, much of which would otherwise go to landfill. The company has developed patented formulations and processes that use less energy and water than conventional tile manufacturing. Post FIPP’s 1H23 end, Alusid successfully collaborated with Imerys, a leader in speciality minerals, to make hard-wearing floor tiles. The result of this collaboration saw Alusid named a winner from 65 companies participating from around the world in the inaugural Imerys Start-Up Innovation Factory competition. During 1H23, Alusid also started supplying a major tile retailer with wall tiles and, according to FIPP, a further announcement is expected soon."

[acuere] 16/3/2023 11:05

Pulsiv in attendance at APEC 2023 next week. North America’s leading conference in the power electronics industry.
Their attendance at Electronica in Germany last November was said to have been a great success. Let’s hope for similar next week.

[rivaldo] 16/3/2023 08:59

Cheers, good to see. I swear ST's following me around my portfolio - that's MWE, FNX and FIPP all tipped on successive days this week :o))

[aqc888] 16/3/2023 07:23

Just appeared in Investors Chronicle tipped by Simon Thompson

[best1467] 16/3/2023 07:20

Eye Watering Indeed Enormously so

[acuere] 15/3/2023 23:01

I’m tempted just to say eye watering.

The technology can be used in a huge range of everyday consumer devices such as televisions, mobile phones and laptops, battery chargers and the micro-inverters used in photovoltaic solar installations.

I can’t find a total figure for these but in 2021 there were over 1.4 billion mobile phones sold.
What I like about the solar power micro inverters is that they can be fitted retrospectively to existing panels. So in the UK alone there are 1.2m households with solar panels. I’m not sure, but if you need a micro inverter for each panel, at an average of say 16 panels per household that’s nearly 20m micro inverters in Uk alone plus anything new fitted.

For a similar company, I would suggest it isn’t just coincidence that CEO Darrel Kingham is ex ARM.

[aqc888] 15/3/2023 21:14

Anyone know the profit margin and size of market potentially on offer to Pulsiv? Or a similar company Pulsiv could perhaps be comparable to one day?

[acuere] 15/3/2023 15:57

Agree hastings.
Pulsivs collaboration announcement yesterday was the second with third pending for USA. A look at Where to Buy on their website shows a lot of the world now covered. And it’s statements like this that get me excited:

“Pulsiv is definitely a game changer and clearly possess a leading technology on the Power Conversion Arena. The expectations and enthusiasm at the Industry are massive.” ISMOsys President, Roberto Blanco.

As said in my last post CamGraphic could be coming to the fore as well now.

The surprise one for me is Nandi Proteins. It looked like it was treading water for past 3 years but again it looks like things be starting to happen.

[hastings] 15/3/2023 15:04

Some very exciting investments here as said before, with seemingly plenty of news to come. I think it is also worth noting that not only is Sir Michael Rake joining the board of CamGraPhIC, he is also an investor which perhaps suggests that this, alongside Pulsiv in particular could prove interesting and potentially significantly rewarding.

[seraha66] 15/3/2023 14:43

Thought the results looked decent.

Like the fact there is plenty of cash in the bank.
Quite important in these uncertain times.

[cordwainer] 15/3/2023 14:38

I would not want to fence words much with Dame Julia King, Baroness Brown of Cambridge DBE FREng FRS FMedSci. Glad she is on our side.

[zipstuck] 15/3/2023 09:38

The Excienta share price is still around that at end of December. So NAV is still good IMHO

[rivaldo] 15/3/2023 09:04

Singer today reiterate their Buy and 125p target price.

The CEO's quote about strong upcoming news flow is particularly good to see.

There are so many exciting developments in the portfolio. Quite apart from the many investees at or beyong inflection points and commercialisation, there are now three graphene tech portfolio companies spun out from Cambridge which could be incredibly exciting.

Pulsiv, Nandi, Alucid, CamGraPhIC, Vaccine Group and Celerum all seem to be making excellent progress.

Singer summarise as follows:

"A maturing portfolio

Frontier IP has reported interim results (H1’23) that reflect a period of strong technical progress but without the large revaluations of previous periods. Net assets per share decreased to 88.2p (FY22: 88.5p) while Net Cash increased to £5.8m providing the Group with a multi-year cash runway. H1’23 saw a number of important commercial and technical developments with FIPP’s management highlighting Pulsiv and Alusid as moving beyond inflection points. A £0.5m pre-tax loss reflects no major net revaluations but Pulsiv and CamGraPhIC raised money in the period and FIPP hosted a well-attended CMD that demonstrated the strength and increasing maturity, of its portfolio. FIPP shares trade at a 22% discount to NAV, we remain at a Buy."

"BUY recommendation

We view FIPP’s NAV as a lagging indicator given multiple milestones are often achieved between mark-to-market valuations. FIPP shares already trade at a 22% discount to NAV before we factor in the potential upside from the Group’s maturing portfolio. We maintain our BUY recommendation and 125p target price."